menu Search
Vyepti

Vyepti

eptinezumab

Manufacturer:

Lundbeck Export A/S
Concise Prescribing Info Bahasa Concise Prescribing Info Full Prescribing Info Contents Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions MIMS Class ATC Classification Regulatory Classification Presentation/Packing
Concise Prescribing Info
Contents
Eptinezumab
Indications/Uses
Prophylaxis of migraine in adults.
Click to view Vyepti detailed prescribing information
Dosage/Direction for Use
100 mg by IV infusion every 12 wk. May be administered as 300 mg by IV infusion every 12 wk.
Click to view Vyepti detailed prescribing information
Overdosage
View Vyepti overdosage for action to be taken in the event of an overdose.
Contraindications
Hypersensitivity.
Click to view Vyepti detailed prescribing information
Special Precautions
Discontinue if serious hypersensitivity reactions occur. Pregnancy & lactation.
Click to view Vyepti detailed prescribing information
Use In Pregnancy & Lactation
Click to view Vyepti detailed prescribing information
Adverse Reactions
Nasopharyngitis, hypersensitivity reactions.
Click to view Vyepti detailed prescribing information
MIMS Class
Antimigraine Preparations
ATC Classification
N02CD05 - eptinezumab ; Belongs to the class of calcitonin gene-related peptide (CGRP) antagonists preparations. Used to relieve migraine.
Regulatory Classification
K
Presentation/Packing
Form
Vyepti infusion conc 100 mg/mL
Packing/Price
1's
Iklan
Iklan
Iklan
Iklan
Iklan
Iklan